dactinomycin and Cancer of Muscle

dactinomycin has been researched along with Cancer of Muscle in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adamkiewicz-Drozynska, E; Bien, E; Fatyga, A; Gabrych, A; Izycka-Swieszewska, E; Kazanowska, B; Krawczyk, MA; Kunc, M; Sokolewicz, EM; Styczewska, M	1
Gandhi, MM; Levitt, GA; Nathan, PC; Weitzman, S	1
Lau, YL; Lee, AC	1

Reviews

1 review(s) available for dactinomycin and Cancer of Muscle

Article	Year
Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomycin; Female; Humans; Infant, Newborn; Male; Methotrexate; Muscle Neoplasms; Myofibromatosis; Osteolysis; Prednisolone; Remission Induction; Respiration, Artificial; Skin Neoplasms; Soft Tissue Neoplasms; Vinblastine; Vincristine	2003

Article

Year

Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy.

Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9

Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Critical Care; Dactinomycin; Female; Humans; Infant, Newborn; Male; Methotrexate; Muscle Neoplasms; Myofibromatosis; Osteolysis; Prednisolone; Remission Induction; Respiration, Artificial; Skin Neoplasms; Soft Tissue Neoplasms; Vinblastine; Vincristine

2003

Other Studies

2 other study(ies) available for dactinomycin and Cancer of Muscle

Article	Year
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2019, Volume: 24, Issue:6 Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine	2019
Chemotherapy-induced veno-occlusive disease of the liver. Medical and pediatric oncology, 1995, Volume: 25, Issue:6 Topics: Abdominal Muscles; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Endodermal Sinus Tumor; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Vincristine	1995

Article

Year

Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals, 2019, Volume: 24, Issue:6

Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine

2019

Chemotherapy-induced veno-occlusive disease of the liver.

Medical and pediatric oncology, 1995, Volume: 25, Issue:6

Topics: Abdominal Muscles; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Endodermal Sinus Tumor; Hepatic Veno-Occlusive Disease; Humans; Infant; Male; Muscle Neoplasms; Neoplasm Recurrence, Local; Vincristine

1995